InMed Pharmaceuticals Inc

+0.78 (+13.59%)
4:47:11 PM EDT: $6.30 -0.22 (-3.37%)
Exchange Changes, Equity Financing / Related

Inmed Announces Share Consolidation To Meet Nasdaq Listing Criteria

Published: 08/23/2022 21:07 GMT
InMed Pharmaceuticals Inc (INM) - Inmed Announces Share Consolidation to Meet Nasdaq Listing Criteria.
Inmed Pharmaceuticals- Common Shares Will Begin Trading on Split-adjusted Basis on Nasdaq Capital Market Commencing at Market Open, September 7, 2022.
Inmed - Will Be Consolidating All Issued & Outstanding Share Capital on Basis of 1 Post‐consolidation Share for Each 25 Pre‐consolidation Shares.